Girls at the Innovate(her) summit high five each other during an activity that illustrates the importance of human emotion during problem solving. [Photo: Rebeca Posadas-Nava]
You'll also learn about a study on an innovative shoulder arthroplasty implant being made by a North Texas company in this roundup of R&D activity aimed at making our lives better.
You'll also find news about research into a possible treatment for melanoma, a deadly form of skin cancer, in this roundup of research activity in laboratories and institutions across North Texas.
Also, you'll learn about the Dallas-based American Heart Association backing research teams looking into age-related cognitive declines, and a Plano-based biotech company getting an approval from the EPA.
She's an art historian, scholar, and director at the Center for BrainHealth. But, perhaps her most innovative work is the creation of Do Something New—a daily practice that makes even the most ordinary of days, extraordinary.
Also, you'll learn about advances to treat Duchenne muscular dystrophy and migraines. Here are some of the research projects underway in North Texas that could make lives better.
Plus, you'll find research on treatments for glucocorticoid-caused glaucoma and improving nuclear waste storage. Here are some of the research projects underway in North Texas aimed at making our lives better.
Also, UT Dallas astrophysicists develop a mathematical tool to help answer why the universe is expanding. Here are some of the research projects and people that make the North Texas research community increasingly important.
Plus, researchers may have found a common link between four neurological conditions. Find out more in the weekly roundup of research and development in Dallas-Fort Worth.
Plus, UT Southwestern examines high-tech mental health strategies. Find out more in the weekly roundup of research and development in Dallas-Fort Worth.
Plus, nicotine has the potential to reduce inflammation in lupus patients and kids with hearing loss are more likely to be bullied. Find out more in our weekly look at R&D in Dallas-Fort Worth.
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
North Texas is a big place with plenty of opportunities. Here’s a curated roundup of contests and competitions; accelerator and recognition programs; and resource and grant opportunities for North Texas innovators. ...
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
North Texas is a big place with plenty of opportunities. Here’s a curated roundup of contests and competitions; accelerator and recognition programs; and resource and grant opportunities for North Texas innovators. ...
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....